Literature DB >> 23353640

External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study.

Edith M Koehler1, Jeoffrey N L Schouten, Bettina E Hansen, Albert Hofman, Bruno H Stricker, Harry L A Janssen.   

Abstract

BACKGROUND & AIMS: We aimed to validate the fatty liver index (FLI), an algorithm that is based on waist circumference, body mass index, and levels of triglyceride and γ-glutamyltransferase. We calculated its ability to identify fatty liver disease from any cause or nonalcoholic fatty liver disease (NAFLD) in a large population of white elderly persons.
METHODS: We collected ultrasonography and FLI data from participants of the Rotterdam Study from February 2009 to February 2012; 2652 subjects (mean age, 76.3 ± 6.0 years) were interviewed and received a clinical examination that included abdominal ultrasound, analysis of blood samples during fasting, and anthropometric assessment. The ability of the FLI to detect (nonalcoholic) fatty liver was assessed by using area under the receiver operator characteristic (AUROC) curve analysis.
RESULTS: FLI score was associated with NAFLD in multivariable analysis (odds ratio, 1.05; 95% confidence interval [CI], 1.04-1.05; P < .001). FLI identified patients with NAFLD with an AUROC curve of 0.813 (95% CI, 0.797-0.830) and those with fatty liver from any cause with an AUROC curve of 0.807 (95% CI, 0.792-0.823).
CONCLUSIONS: The FLI (an algorithm that is based on waist circumference, body mass index, and levels of triglyceride and γ-glutamyltransferase) accurately identifies NAFLD, confirmed via ultrasonography, in a large, white, elderly population. Published by Elsevier Inc.

Entities:  

Keywords:  AUROC; CI; Epidemiology; FLI; HOMA-IR; LAP; Lipid Accumulation Product; NAFLD; Obesity; The Netherlands; area under the receiver operator characteristic; confidence interval; fatty liver index; homeostasis model assessment of insulin resistance; lipid accumulation product; nonalcoholic fatty liver disease

Mesh:

Substances:

Year:  2013        PMID: 23353640     DOI: 10.1016/j.cgh.2012.12.031

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  66 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Mediterranean diet.

Authors:  Martin Hofmeister
Journal:  Dtsch Arztebl Int       Date:  2015-02-27       Impact factor: 5.594

Review 3.  Epidemiology of fatty liver: an update.

Authors:  Giorgio Bedogni; Valerio Nobili; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

4.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

5.  Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?

Authors:  Luca Montesi; Chiara Caselli; Elena Centis; Chiara Nuccitelli; Simona Moscatiello; Alessandro Suppini; Giulio Marchesini
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 6.  Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.

Authors:  Jia-Zhen Zhang; Jing-Jing Cai; Yao Yu; Zhi-Gang She; Hongliang Li
Journal:  Gene Expr       Date:  2019-04-22

Review 7.  Clinical approaches to non-alcoholic fatty liver disease.

Authors:  Katherine J P Schwenger; Johane P Allard
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

8.  Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.

Authors:  Nima Motamed; Masoudreza Sohrabi; Hossein Ajdarkosh; Gholamreza Hemmasi; Mansooreh Maadi; Fatemeh Sima Sayeedian; Reza Pirzad; Khadijeh Abedi; Sivil Aghapour; Mojtaba Fallahnezhad; Farhad Zamani
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 9.  Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.

Authors:  Erin K Spengler; Rohit Loomba
Journal:  Mayo Clin Proc       Date:  2015-07-26       Impact factor: 7.616

10.  Liver in the analysis of body composition by dual-energy X-ray absorptiometry.

Authors:  A Bazzocchi; D Diano; U Albisinni; G Marchesini; G Battista; G Guglielmi
Journal:  Br J Radiol       Date:  2014-06-12       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.